Data gathered: May 17
Alternative Data for Soleno Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 69 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| Patents | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 7,607 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 42 | Sign up | Sign up | Sign up |
About Soleno Therapeutics
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
| Price | $46.16 |
| Target Price | Sign up |
| Volume | 334,440 |
| Market Cap | $1.67B |
| Year Range | $3.9 - $52.35 |
| Dividend Yield | 0% |
| Revenue per Employee | $0 |
| Industry | Biotechnology |
In the news
Soleno Therapeutics management to meet with Piper SandlerMay 15 - Thefly.com |
|
 |
Soleno Therapeutics launches initiative in honor of PWS Awareness DayMay 15 - Thefly.com |
 |
Soleno Therapeutics Stands with the Prader-Willi Syndrome CommunityMay 15 - Investing.com |
 |
Analysts Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Price Target at $55.60May 14 - ETF Daily News |
|
Soleno Therapeutics (NASDAQ:SLNO) PT Lowered to $59.00May 13 - ETF Daily News |
 |
Soleno Therapeutics price target lowered by $6 at Oppenheimer, here's whyMay 13 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '23 | 0 | 4.6M | -4.6M | -11M | -13M | -0.330 |
| Q3 '23 | 0 | 3.3M | -3.3M | -11M | -9.9M | -0.950 |
| Q2 '23 | 0 | 3.2M | -3.2M | -8.5M | -8.1M | -0.810 |
| Q1 '23 | 0 | 3.3M | -3.3M | -8.4M | -8M | -0.880 |
| Q4 '22 | 0 | 2.9M | -2.9M | -5.5M | -5.1M | -0.580 |
Insider Transactions View All
| Vivo Opportunity, LLC filed to sell 7,316,851 shares at $45.1. May 1 '24 |
| Vivo Opportunity, LLC filed to sell 7,668,093 shares at $47.8. May 1 '24 |
| Hirano Patricia C filed to sell 50,924 shares at $41.7. April 3 '24 |
| Yen Kristen filed to sell 23,422 shares at $41.7. April 3 '24 |
| Anish Bhatnagar filed to sell 152,790 shares at $41.7. April 3 '24 |
Similar companies
Read more about Soleno Therapeutics (SLNO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Soleno Therapeutics?
The Market Cap of Soleno Therapeutics is $1.67B.
How Many People Work at Soleno Therapeutics?
As of our latest update, Soleno Therapeutics employed approximately 25 people worldwide. However, it's important to note that Soleno Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Soleno Therapeutics' revenue per employee?
$0. To calculate Soleno Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Soleno Therapeutics?
Currently, the price of one share of Soleno Therapeutics stock is $46.16.
How can I analyze the SLNO stock price chart for investment decisions?
The SLNO stock price chart above provides a comprehensive visual representation of Soleno Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Soleno Therapeutics shares. Our platform offers an up-to-date SLNO stock price chart, along with technical data analysis and alternative data insights.
Does SLNO offer dividends to its shareholders?
As of our latest update, Soleno Therapeutics (SLNO) does not offer dividends to its shareholders. Investors interested in Soleno Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Soleno Therapeutics?
Some of the similar stocks of Soleno Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.